China Aoxing Pharmaceutical Company Announce March Investor Conferences Participation
March 01 2010 - 7:00AM
Marketwired
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China
Aoxing"), a China-based pharmaceutical company specializing in
research, development, manufacturing and distribution of narcotic
and pain-management products, today announced the Company's
participation in the following conferences.
-- Rodman & Renshaw Annual China Investment Conference, to be held
March 7-9, 2010 at the Regent Hotel, Beijing, China. Management present
at 11:05 am Beijing Time on March 8 and meet with institutional
investors throughout March 8 and 9;
-- Roth 22nd Annual OC Growth Stock Conference, to be held March 14-17,
2010 at The Ritz-Carlton, Laguna Niguel, California. Management present
at 8:00 am Pacific Time on March 17 and meet institutional investors
throughout March 16 and 17.
For further details, please contact your institutional sales
representative.
About China Aoxing Pharmaceutical Company, Inc.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) is a
pharmaceutical company located in China specializing in research,
development, manufacturing and distribution of a variety of
narcotics and pain-management products. It has international
strategic alliances with QRxPharma Limited and American Oriental
Bioengineering, Inc. (NYSE: AOB) in commercializing narcotic and
pain management products for China and ex-China markets.
Headquartered in Shijiazhuang City, the pharmaceutical capital of
China, outside of Beijing, China Aoxing has China's largest and the
most advanced manufacturing facility for highly regulated narcotic
medicines, addressing a very under-served and fast-growing market
in China. Its facility is one of the few GMP facilities licensed
for narcotics medicines. The Company is working closely with the
Chinese government and SFDA to assure the strictly regulated
availability to medical professionals of its narcotic drugs and
pain medicines throughout China. For more information:
www.chinapainmed.com.
Statements made in this press release are forward-looking and
are made pursuant to the safe harbor provisions of the Securities
Litigation Reform Act of 1995. Such statements involve risks and
uncertainties that may cause actual results to differ materially
from those set forth in these statements. The economic,
competitive, governmental, technological and other risk factors
identified in the Company's filings with the Securities and
Exchange Commission, including the Form 10-K for the year ended
June 30, 2009, may cause actual results or events to differ
materially from those described in the forward looking statements
in this press release. The Company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
because of new information, future events, or otherwise.
Investor Relations Contact: Brian Korb Vice President The Troup
Group LLC Tel: +1 646 378 2923 Email: bkorb@troutgroup.com Website:
www.chinapainmed.com
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jul 2023 to Jul 2024